Sebastien Bergeret
Overview
Explore the profile of Sebastien Bergeret including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
46
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roussel-Simonin C, Gougis P, Lassoued D, Vozy A, Veyri M, Morardet L, et al.
Acta Oncol
. 2023 Jun;
62(6):579-586.
PMID: 37276270
Background: Small-cell lung cancer (SCLC) accounts for approximately 15% of lung cancer and is associated with poor prognosis. In platinum-refractory or -resistant SCLC patients, few treatment options are available. Topotecan...
2.
Bergeret S, Birzu C, Meneret P, Giron A, Demeret S, Marois C, et al.
Biomedicines
. 2023 Feb;
11(2).
PMID: 36831042
Introduction: Autoimmune encephalitis (AE) diagnosis and follow-up remain challenging. Brain F-fluoro-deoxy-glucose positron emission tomography (FDG PET) has shown promising results in AE. Our aim was to investigate FDG PET alterations...
3.
Lespinasse J, Chene G, Mangin J, Dubois B, Blanc F, Paquet C, et al.
Alzheimers Dement
. 2022 Dec;
19(6):2332-2342.
PMID: 36464896
Introduction: Approximately 40% of dementia cases could be delayed or prevented acting on modifiable risk factors including hypertension. However, the mechanisms underlying the hypertension-dementia association are still poorly understood. Methods:...
4.
Soret M, Maisonobe J, Desarnaud S, Bergeret S, Causse-Lemercier V, Berenbaum A, et al.
Sci Rep
. 2022 Sep;
12(1):15341.
PMID: 36097015
We previously showed that the injected activity could be reduced to 1 MBq/kg without significantly degrading image quality for the exploration of neurocognitive disorders in 18F-FDG-PET/MRI. We now hypothesized that...
5.
Soret M, Maisonobe J, Payen S, Gaubert A, Brunel S, Bergeret S, et al.
J Radiol Prot
. 2022 Mar;
42(2).
PMID: 35296565
Since 2010, positron emission tomography/magnetic resonance (PET/MR) has been increasingly used as clinical routine in nuclear medicine departments. One advantage of PET/MR over PET/computed tomography (CT) is the lower dose...
6.
Hybrid [F]-F-DOPA PET/MRI Interpretation Criteria and Scores for Glioma Follow-up After Radiotherapy
Bertaux M, Berenbaum A, Di Stefano A, Rozenblum L, Soret M, Bergeret S, et al.
Clin Neuroradiol
. 2022 Feb;
32(3):735-747.
PMID: 35147721
Objective: F‑fluoro-L‑3,4‑dihydroxyphenylalanine positron emission tomography (F‑DOPA PET) is used in glioma follow-up after radiotherapy to discriminate treatment-related changes (TRC) from tumor progression (TP). We compared the performances of a combined...
7.
Dupin N, Jary A, Boussouar S, Syrykh C, Gandjbakhche A, Bergeret S, et al.
Cancers (Basel)
. 2021 Dec;
13(23).
PMID: 34885035
Kaposi's sarcoma (KS) is a rare, atypical malignancy associated with immunosuppression and can be qualified as an opportunistic tumor, which responds to immune modulation or restoration. Four different epidemiological forms...
8.
Bergeret S, Queneau M, Rodallec M, Landeau B, Chetelat G, Hong Y, et al.
Stroke
. 2021 Feb;
52(4):1478-1482.
PMID: 33611942
Background And Purpose: The in vivo diagnosis of cerebral amyloid angiopathy (CAA) is currently based on the Boston criteria, which largely rely on hemorrhagic features on brain magnetic resonance imaging....
9.
Bergeret S, Queneau M, Rodallec M, Curis E, Dumurgier J, Hugon J, et al.
Eur J Neurol
. 2021 Jan;
28(5):1511-1519.
PMID: 33460498
Background: Cerebral amyloid angiopathy (CAA) is a frequent cause of both intracerebral hemorrhage (ICH) and cognitive impairment in the elderly. Diagnosis relies on the Boston criteria, which use magnetic resonance...
10.
Bertaux M, Houillier C, Edeline V, Habert M, Mokhtari K, Giron A, et al.
J Neurooncol
. 2020 May;
148(2):343-352.
PMID: 32405997
Introduction: Primary Central Nervous System Lymphoma (PCNSL) is a rare disease with different therapeutic implications than systemic lymphoma. In this study, we evaluated whole-body FDG-PET/CT for pre-chemotherapy imaging of suspected...